This is an excerpt, the entire story is on our affiliate website LosAngelesHealthAndBeauty.com
One of the first in the country, plastic surgeon Dr. Grant Stevens announces the addition of the BOTOX alternative Xeomin to his plastic surgery practice in Los Angeles. Receiving FDA approval earlier this year, the botulinum toxin Xeomin will become available nationwide early spring 2012. However, select premier practices, such as Marina Plastic Surgery Associates in Marina Del Rey already have the product and are offering it to patients as a more cost effective alternative to BOTOX or Dysport.
FDA trials for Xeomin included 2 studies with 16 clinics and 547 healthy adult participants. After 30 days, patients who were injected with Xeomin showed great improvement in the glabellar (frown lines) region vs. those that were injected with the placebo. FDA approved for treating the glabellar lines, physicians may choose to administer it off-label to treat fine lines, wrinkles and Crows Feet. "Xeomin is a neurotoxin; it is helpful for reducing wrinkles and it achieves the same results that BOTOX does," describes Los Angeles Xeomin provider Dr. Grant Stevens, "Xeomin appears to work the same as BOTOX but it differs in that it is a smaller molecule."
Like BOTOX, Xeomin works by attaching itself to the nerve endings. Botulinum toxins are injected directly into the muscle and block the signals that the brain normally sends to tell them to contract, essentially paralyzing the muscle. Unlike BOTOX, Xeomin's molecular structure does not contain complex proteins. Because of this, patients who have had allergic reactions to BOTOX may have another chance at treating wrinkles with Xeomin in Los Angeles
Read the entire article at LosAngelesHealthAndBeauty.com